3,4-Methylenedioxy-N-methoxyamphetamine

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
3,4-Methylenedioxy-N-methoxyamphetamine
MDMEO.png
Names
IUPAC name
1-(1,3-benzodioxol-5-yl)-N-methoxypropan-2-amine
Identifiers
74698-48-9 YesY
ChemSpider 21106333 YesY
Jmol 3D model Interactive image
  • InChI=1S/C11H15NO3/c1-8(12-13-2)5-9-3-4-10-11(6-9)15-7-14-10/h3-4,6,8,12H,5,7H2,1-2H3 YesY
    Key: MTIKJUJMCMDSGM-UHFFFAOYSA-N YesY
  • InChI=1/C11H15NO3/c1-8(12-13-2)5-9-3-4-10-11(6-9)15-7-14-10/h3-4,6,8,12H,5,7H2,1-2H3
    Key: MTIKJUJMCMDSGM-UHFFFAOYAV
  • CC(NOC)Cc1ccc2OCOc2c1
Properties
C11H15NO3
Molar mass 209.25 g·mol−1
Vapor pressure {{{value}}}
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
YesY verify (what is YesYN ?)
Infobox references

3,4-Methylenedioxy-N-methoxyamphetamine (MDMEO, MDMEOA, or MDMeOA) is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N-methoxy analogue of MDA. MDMEO was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 180 mg. MDMEO may be found as white crystals. It produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEO.

See also

References

External links


<templatestyles src="Asbox/styles.css"></templatestyles>